These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8442292)

  • 1. Reduction in primary nonfunction of pancreas islet transplants with antithymocyte globulin agents, deoxyspergualin, and splenectomy.
    Pittman K; Thomas F; McFadden T; Haisch C; Thomas J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):986-7. PubMed ID: 8442292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxyspergualin and rabbit antithymocyte globulin markedly prolong discordant pig pancreatic islet xenografts.
    Henretta J; Pittman K; McFadden T; Thomas J; Thomas F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):412-3. PubMed ID: 8438358
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction of primary nonfunction in discordant pancreas islet xenografts.
    Pittman K; Thomas J; Thomas F
    Transplant Proc; 1992 Apr; 24(2):649-50. PubMed ID: 1566465
    [No Abstract]   [Full Text] [Related]  

  • 4. Deoxyspergualin is a unique immunosuppressive agent with selective utility in inducing tolerance to pancreas islet xenografts.
    Thomas F; Pittman K; Ljung T; Cekada E
    Transplant Proc; 1995 Feb; 27(1):417-9. PubMed ID: 7879045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term (10-month) pig islet xenograft tolerance using measured total lymphoid irradiation, splenectomy, short-term rabbit antithymocyte globulin, and deoxyspergualin without long-term immunosuppression.
    Llyung T; Contreras J; Thomas F; Pittman K; Thomas J
    Transplant Proc; 1999; 31(1-2):962-3. PubMed ID: 10083428
    [No Abstract]   [Full Text] [Related]  

  • 6. Six- to eight-month survival of discordant pig islet xenografts documented by differential species, insulin, and C-peptide in animals given short-term immunosuppression.
    Henretta J; McFadden T; Pittman K; Thomas J; Thomas F
    Transplant Proc; 1994 Jun; 26(3):1138-9. PubMed ID: 8029861
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful discordant pancreatic islet xenotransplantation by prevention of primary nonfunction graft rejection and autoimmune disease recurrence.
    Henretta J; Pittman K; McFadden T; Thomas F
    Transplant Proc; 1994 Jun; 26(3):1133-4. PubMed ID: 8029859
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of primary nonfunction of xenograft islets.
    Pittman K; Henretta J; McFadden T; Thomas J; Thomas FT
    Transplant Proc; 1994 Jun; 26(3):1141-2. PubMed ID: 8029862
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversal of type II diabetes by pancreas islet transplant in four separate animal models of type II diabetes.
    Thomas F; Pittman K; McFadden T; Haisch C; Peterson R; Thomas J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):992-3. PubMed ID: 8442295
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of discordant islet xenografts for the treatment of type II diabetes.
    Pittman K; Henretta J; Thomas J; Thomas F
    Transplant Proc; 1994 Jun; 26(3):1135-7. PubMed ID: 8029860
    [No Abstract]   [Full Text] [Related]  

  • 11. Pig-to-human islet transplantation in eight patients.
    Tibell A; Groth CG; Möller E; Korsgren O; Andersson A; Hellerström C
    Transplant Proc; 1994 Apr; 26(2):762-3. PubMed ID: 8171652
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful combination therapy with FK 506 and 15-deoxyspergualin in pancreatic islet xenografting.
    Hisanaga M; Nakajima Y; Yabuuchi H; Nakano H
    Transplant Proc; 1992 Jun; 24(3):1043-4. PubMed ID: 1376513
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreas islet xenografts but not allografts are resistant to autoimmune disease recurrence following islet transplantation.
    Thomas FT; Pittman K; Brezina P; Wu J; Mountz J; Contreras J; Thomas J
    Transplant Proc; 1997; 29(1-2):760-1. PubMed ID: 9123513
    [No Abstract]   [Full Text] [Related]  

  • 14. Perioperative immunosuppression as a critical determinant of early outcome after discordant xenoislet transplantation: a comparative study.
    Troppmann C; Papalois BE; Gruessner AC; Moon C; Matas AJ; Sehgal SN; Nakhleh RE; Gruessner RW
    Transplant Proc; 1996 Apr; 28(2):981-3. PubMed ID: 8623487
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful long-term pancreatic islet cell xenotransplantation and functional tolerance in NOD mice.
    Ljung T; Pittman K; Thomas FT
    Transplant Proc; 1995 Feb; 27(1):1351-2. PubMed ID: 7878908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary nonfunction of islet xenografts in rat recipients results from non-T-cell-mediated immune responses.
    Deng S; Ketchum RJ; Kucher T; Weber M; Naji A; Brayman KL
    Transplant Proc; 1997 May; 29(3):1726-7. PubMed ID: 9142249
    [No Abstract]   [Full Text] [Related]  

  • 17. Survival of human islet xenografts irradiated with ultraviolet B in diabetic rats.
    Sung RS; Fiedor PS; Yaron I; Zakheim AR; Quadracci KM; Goodman ER; Hardy MA
    Transplant Proc; 1996 Apr; 28(2):839. PubMed ID: 8623427
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of low doses of 15-deoxyspergualin in agarose-microencapsulated discordant islet xenotransplantation.
    Aomatsu Y; Nakajima Y; Iwata H; Amemiya H; Kanehiro H; Hisanaga M; Yoshimura A; Kido K; Taki J; Horikawa M
    Transplant Proc; 1995 Feb; 27(1):292-3. PubMed ID: 7879008
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of xenograft resistance to autoimmune disease recurrence after pancreas islet transplantation.
    Thomas F; Pittman K; Larkin E; Berzina P; Contreras J; Quarantillo P; Thomas J
    Transplant Proc; 1999; 31(1-2):964-5. PubMed ID: 10083429
    [No Abstract]   [Full Text] [Related]  

  • 20. Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade.
    Bühler L; Deng S; O'Neil J; Kitamura H; Koulmanda M; Baldi A; Rahier J; Alwayn IP; Appel JZ; Awwad M; Sachs DH; Weir G; Squifflet JP; Cooper DK; Morel P
    Xenotransplantation; 2002 Jan; 9(1):3-13. PubMed ID: 12005102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.